Compare Amphastar Pharmaceuticals Inc (AMPH) vs Riot Platforms Inc (RIOT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Riot Platforms Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $18.72 (market cap $826.08M), while Riot Platforms Inc trades at $20.74 (market cap $7.93B). The key difference: Riot Platforms Inc is far larger — about 9.6× Amphastar Pharmaceuticals Inc's market cap, and Riot Platforms Inc is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| AMPH | RIOT | |
|---|---|---|
Market Cap | $826.08M | $7.93B |
Sector | Health | Technology |
52-Week High | $30.81 | $28.67 |
52-Week Low | $16.87 | $11.03 |
Enterprise Value | $1.22B | $8.60B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.
The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.
RIOT trades at $20.97, down 2.58% today, with a bearish technical signal. Recent earnings show mixed results, beating in Q3 2025 but missing in Q4 2025 and Q1 2026. The company reported a net loss of $663 million in 2025 despite $647 million revenue. Analyst consensus is strongly bullish with a $27.86 price target. News highlights volatility tied to Bitcoin trends and a strategic pivot toward AI data centers.
Outlook remains speculative with high valuation multiples amid persistent losses. Opportunities include expansion into high-performance computing, but risks involve cash flow deficits, competitive pressures, and sensitivity to cryptocurrency markets. Investors should weigh analyst optimism against fundamental challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Riot Platforms Inc
Riot Platforms, Inc. is a Bitcoin mining company that focuses on building, operating, and expanding large-scale infrastructure for digital asset mining in North America. The company's operations include Bitcoin mining, data center hosting, and engineering solutions. Riot's strategy emphasizes vertical integration to maximize efficiency and scale its mining capacity, aiming to be a leader in the global Bitcoin and digital infrastructure industry.
Read more on RIOT →
